學門類別
最新個案
- Leadership Imperatives in an AI World
- Vodafone Idea Merger - Unpacking IS Integration Strategies
- V21 Landmarks Pvt. Ltd: Scaling Newer Heights in Real Estate Entrepreneurship
- Snapchat’s Dilemma: Growth or Financial Sustainability
- Did I Just Cross the Line and Harass a Colleague?
- Predicting the Future Impacts of AI: McLuhan’s Tetrad Framework
- Porsche Drive (A) and (B): Student Spreadsheet
- Porsche Drive (B): Vehicle Subscription Strategy
- TNT Assignment: Financial Ratio Code Cracker
- Winsol: An Opportunity For Solar Expansion
Welcome Pharmaceuticals
內容大綱
Welcome Pharmaceuticals was a joint venture between North China Pharmaceutical Corp. and Hong Kong Triple Well International and is a leading producer of vitamin C in China. The company's general manager had just returned from an industry wide meeting, and was disturbed by what he had learned: there was a worldwide oversupply of vitamin C and already sagging prices had not yet hit rock bottom. The general manager knew the only way for Welcome to survive was to reduce costs, and because Welcome's material costs were already among the lowest in the industry, the only area left to trim was labor costs. The management team was called together to decide whether this was, in fact, the company's only option. If so, the management team had to quickly decide how to go about effecting what was bound to be an unpopular change among several tiers of workers.